NUDT3 Activators
NUDT3 Activators are a specialized group of chemical compounds that indirectly enhance the functional activity of NUDT3 through specific signaling pathways predominantly centered around the cyclic AMP (cAMP) cascade. Forskolin, a direct stimulator of adenylyl cyclase, increases cAMP levels, leading to the activation of protein kinase A (PKA), which is known to phosphorylate and activate NUDT3, thereby amplifying its regulatory role in signal transduction and metabolism. IBMX and Dipyridamole, both phosphodiesterase inhibitors, prolong the life of cAMP within the cell, indirectly elevating PKA activity and, in turn, NUDT3 function. Similarly, Rolipram and Cilostamide, by selectively inhibiting phosphodiesterase 4 and 3 respectively, allow for a sustained increase in cAMP, which is instrumental for the PKA-mediated enhancement of NUDT3. The unique Epac activator 5376753, by triggering Epac, a cAMP-activated guanine nucleotide exchange factor, sets off a cascade that ultimately potentiates NUDT3's activity, exemplifying a distinct but complementary pathway to the classical PKA route.
Continuing with this theme, other compounds like PGE1, Anagrelide, and Zardaverine also promote the accumulation of cAMP, further buttressing the PKA-mediated phosphorylation and enhancement of NUDT3. Milrinone and Trequinsin, as selective phosphodiesterase 3 inhibitors, and Glucagon, an adenylate cyclase activator, all serve to elevate cAMP and therefore PKA activity, culminating in the enhanced activation of NUDT3. This fine-tuned orchestration of NUDT3 activity by these activators underscores their pivotal role in optimizing NUDT3's functionality, which is crucial for its involvement in a multitude of cellular processes, including but not limited to signal transduction, metabolism, and potentially other cAMP/PKA regulated pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, increasing cyclic AMP (cAMP) levels in cells. Elevated cAMP activates protein kinase A (PKA), which can phosphorylate NUDT3, leading to its activation. This enhancement of NUDT3 activity is essential in its role in modulating cellular processes such as signal transduction and metabolism. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX (3-Isobutyl-1-methylxanthine) is a nonspecific inhibitor of phosphodiesterases, enzymes that degrade cAMP and cGMP. By preventing the breakdown of these cyclic nucleotides, IBMX indirectly increases their intracellular levels, thereby potentiating the PKA pathway and subsequently enhancing the activity of NUDT3. | ||||||
Dipyridamole | 58-32-2 | sc-200717 sc-200717A | 1 g 5 g | $31.00 $102.00 | 1 | |
Dipyridamole is another phosphodiesterase inhibitor that increases cAMP by preventing its degradation. The elevated cAMP levels activate PKA, which then can enhance the activity of NUDT3 through phosphorylation. This mechanism underscores the indirect influence of dipyridamole on NUDT3 activity related to its cellular functions. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram selectively inhibits phosphodiesterase 4, leading to an increase in cAMP levels within the cell. The rise in cAMP activates PKA, which in turn can phosphorylate and activate NUDT3. This activity enhancement of NUDT3 contributes to its regulatory functions in various cellular pathways, including signal transduction and metabolism. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
Cilostamide is a selective inhibitor of phosphodiesterase 3, which increases cAMP levels in cells by preventing its breakdown. The resulting activation of PKA can lead to the phosphorylation and activation of NUDT3, thus enhancing its functional activity within the cell. | ||||||
PGE1 (Prostaglandin E1) | 745-65-3 | sc-201223 sc-201223A | 1 mg 10 mg | $31.00 $145.00 | 16 | |
Prostaglandin E1 (PGE1) activates adenylate cyclase, thereby increasing cAMP levels and subsequently activating PKA, which can phosphorylate and enhance the activity of NUDT3. This mechanism delineates the indirect pathway through which PGE1 can enhance NUDT3 function in the cell. | ||||||
Anagrelide hydrochloride | 58579-51-4 | sc-203513 sc-203513A | 10 mg 50 mg | $103.00 $587.00 | 1 | |
Anagrelide inhibits phosphodiesterase 3, leading to increased cAMP levels in the cell. This rise in cAMP activates PKA, which may enhance NUDT3 activity through phosphorylation. Such enhancement is crucial for NUDT3's role in modulating cellular processes. | ||||||
Zardaverine | 101975-10-4 | sc-201208 sc-201208A | 5 mg 25 mg | $88.00 $379.00 | 1 | |
Zardaverine is a dual inhibitor of phosphodiesterases 3 and 4, which increases intracellular cAMP and activates PKA. This activation can lead to the phosphorylation and subsequent enhancement of NUDT3 activity, which is pivotal in its role in cellular signaling and metabolism. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $165.00 $697.00 | 7 | |
Milrinone is a selective phosphodiesterase 3 inhibitor, which causes an increase in intracellular cAMP levels, activating PKA. PKA then can phosphorylate NUDT3, leading to its activation. This mechanism highlights the indirect influence of milrinone on the functional activity of NUDT3. | ||||||